Patient Blood Management Market Scenario
Increasing demand for donated blood, technological advancements in the field of patient blood management and rising prevalence of target diseases are some of the major factors propelling the patient blood management market globally. Furthermore, increasing number of blood donations and blood donors is also one of the factor propelling the growth of patient blood management market. However, high cost associated with automated systems is one of the major factor expected to hamper the global growth of the market.
Patient Blood Management Market Segmentation
The Patient Blood Management Market is segmented by Product, Component, End User and Geography. The product studied in the patient blood management market are Instruments (Blood Processing Devices, Blood Transfusion Devices, Blood Culture Screening Devices, Diagnostic & Testing Instruments and Blood Storage Devices), Accessories, Reagents and Kits and Software. Furthermore, the component segment comprises of Whole Blood & Red Blood Cells and Plasma. Likewise, various End Users of this market are Blood Banks, Hospitals and Diagnostic Clinics and & Pathology Labs. Based on Geography, the Patient Blood Management Market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW.
Patient Blood Management Market by Geography
Based on geography, the patient blood management market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW. Among all the regions, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. China and India are expected to offer significant growth opportunities for players in the market, mainly due to the rising patient pool, growing support from government bodies, and the rising awareness about blood transfusion.
Patient Blood Management Market Key Players
Some of the major players operating in the global patient blood management market includes Haemonetics Corporation, Fresenius Se & Co. KGaA, Terumo Corporation, Immucor, Inc., B. Braun, Melsungen AG, Macopharma, Biomérieux SA, Asahi Kasei Medical Co. Ltd. (A Subsidiary of Asahi Kasei Corporation), Kaneka Corporation, Bio-Rad Laboratories, Inc., Abbott Laboratories, Grifols, S.A., F. Hoffmann-La Roche LTD., Livanova PLC and Danaher Corporation. Many companies in this market implement initiatives such as mergers and acquisitions, product developments, and geographic penetration to compete in the market.
Patient Blood Management Market Report Key Benefits